The prevalence of metabolic syndrome components, individually and in combination, in male patients admitted with acute coronary syndrome, without previous diagnosis of diabetes mellitus

Libyan Journal of Medicine

Volumn 8, Issue 1, 2013, Pages

  Al Aqeedi, Rafid Fayadh ^a   Abdulatif, Waleed Khalid ^a,b   Dabdoob, Wafer ^a,b   Bener, Abdulbari ^a,b   Albinali, Hajar A ^a   Gehani, Abdurrazzak ^a,b  

^a HAMAD MEDICAL CORPORATION   (Qatar)

^b WEILL CORNELL MEDICAL COLLEGE   (Qatar)

Author keywords

Acute coronary syndrome; Diabetes mellitus; Male; Metabolic syndrome

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DISEASE ASSOCIATION; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT; PREVALENCE; PROSPECTIVE STUDY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SYNDROME DELINEATION; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

EID: 84875297894     PISSN: 19932820     EISSN: 18196357     Source Type: Journal    
DOI: 10.3402/ljm.v8i0.20185     Document Type: Article

References (20)

1. Levantesi G, Macchia A, Marfisi RA, Franzosi MG, Maggioni AP, Nicolosi GL, et al. Metabolic syndrome and risk of cardiovascular events after myocardial infarction. J Am Coll Cardiol. 2005; 46: 277-83.
2. Zeller M, Steg PG, Ravisy J, Laurent Y, Janin-Manificat L, L'Huillier I, et al. Prevalence and impact of metabolic syndrome on hospital outcomes in acute myocardial infarction. Arch Intern Med. 2005; 165: 1192-8.
3. Schwartz GG, Szarek M, Olsson AG, Sasiela WJ. Relation of characteristics of metabolic syndrome to short term prognosis and effects of statin therapy after acute coronary syndrome. Diabetes Care. 2005; 28: 2508-13.
4. Feinberg MS, Schwartz R, Tanne D, Fisman EZ, Hod H, Zahger D, et al. Impact of the metabolic syndrome on the clinical outcomes of non-clinically diagnosed diabetic patients with acute coronary syndrome. Am J Cardiol. 2007; 99: 667-72.
5. Nakatani D, Sakata Y, Sato H, Mizuno H, Shimizu M, Suna S, et al. Clinical impact of metabolic syndrome and its additive effect with smoking on subsequent cardiac events after acute myocardial infarction. Am J Cardiol. 2007; 99: 885-9.
6. Milani RV, Lavie CJ. Prevalence and profile of metabolic syndrome in patients following acute coronary events and effects of therapeutic lifestyle change with cardiac rehabilitation. Am J Cardiol. 2003; 92: 50-4.
7. Jover A, Corbella E, Munoz A, Millán J, Pintó X, Mangas A, et al. Prevalence of metabolic syndrome and its components in patients with acute coronary syndrome. Rev Esp Cardiol. 2011; 64: 579-86.
8. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome. A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009; 120: 1640-5.
9. 2011 Qatar statistics authority. Available from: www.qsa.gov.qa/eng/index.htm [cited 20 September 2011].
10. Morrow DA, Antman EM, Charlesworth A, Cairns R, Murphy SA, de Lemos JA, et al. TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation. An intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation. 2000; 102: 2031-7.
11. Braunwald E. Unstable angina. A classification. Circulation. 1989; 80: 410-4.
12. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002; 106: 3143-421.
13. World Health Organization (1999). Definition, diagnosis and classification of diabetes and its complications: report of a WHO consultation. Geneva: World Health Organization.
14. Birhan Yilmaz M, Guray U, Guray Y, Altay H, Demirkan B, Caldir V, et al. Metabolic syndrome is associated with extension of coronary artery disease in patients with non-ST segment elevation acute coronary syndromes. Coron Artery Dis. 2005; 16: 287-92.
15. Elbarasi E, Goodman SG, Yan RT, Welsh RC, Kornder J, Wong GC, et al. Management patterns of non-ST segment elevation acute coronary syndromes in relation to prior coronary revascularization. Am Heart J. 2010; 159: 40-6.
16. Solymoss BC, Bourassa MG, Campeau L, Sniderman A, Marcil M, Lespe ́rance J, et al. Effect of increasing metabolic syndrome score on atherosclerotic risk profile and coronary artery disease angiographic severity. Am J Cardiol. 2004; 93: 159-64.
17. Musallam M, Bener A, Zirie M, Al-Gaud Y, Al-Hamaq A, Othman M, et al. Metabolic syndrome and its components among Qatari population. Int J Food Saf Nutr Public Health. 2008; 1: 88-102.
18. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement (published corrections appear in Circulation. 2005; 112: e297 and Circulation. 2005; 112: e298). Circulation. 2005; 112: 2735-52.
19. Al-Lawati JA, Mohammed AJ, Al-Hinai HQ, Jousilahti P. Prevalence of the metabolic syndrome among Omani adults. Diabetes Care. 2003; 26: 1781-5.
20. Al-Qahtani DA, Imtiaz ML. Prevalence of metabolic syndrome in Saudi adult soldiers. Saudi Med J. 2005; 26: 1360-6.